These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39126118)

  • 1. CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer.
    Wesener MC; Weiler SME; Bissinger M; Klessinger TF; Rose F; Merker S; Luzarowski M; Ruppert T; Helm B; Klingmüller U; Schirmacher P; Breuhahn K
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
    Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
    Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.
    Lin M; Zheng X; Yan J; Huang F; Chen Y; Ding R; Wan J; Zhang L; Wang C; Pan J; Cao X; Fu K; Lou Y; Feng XH; Ji J; Zhao B; Lan F; Shen L; He X; Qiu Y; Jin J
    Nat Commun; 2024 Jun; 15(1):4995. PubMed ID: 38862474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-canonical repressor function of JUN restrains YAP activity and liver cancer growth.
    Kurlishchuk Y; Cindric Vranesic A; Jessen M; Kipping A; Ritter C; Kim K; Cramer P; von Eyss B
    EMBO J; 2024 Oct; 43(20):4578-4603. PubMed ID: 39210147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.
    Lei L; Wu J; Gu D; Liu H; Wang S
    Tumour Biol; 2016 Aug; 37(8):11073-9. PubMed ID: 26906552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.
    Saito Y; Yin D; Kubota N; Wang X; Filliol A; Remotti H; Nair A; Fazlollahi L; Hoshida Y; Tabas I; Wangensteen KJ; Schwabe RF
    Gastroenterology; 2023 Jun; 164(7):1279-1292. PubMed ID: 36894036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway.
    Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C
    Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
    Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
    Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
    J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation.
    Cho K; Ro SW; Lee HW; Moon H; Han S; Kim HR; Ahn SH; Park JY; Kim DY
    Hepatology; 2021 Nov; 74(5):2605-2621. PubMed ID: 34101869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
    Wang H; Wang J; Zhang S; Jia J; Liu X; Zhang J; Wang P; Song X; Che L; Liu K; Ribback S; Cigliano A; Evert M; Wu H; Calvisi DF; Zeng Y; Chen X
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1095-1117. PubMed ID: 33232824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous knockdown of YAP and TAZ increases apoptosis of hepatocellular carcinoma cells under hypoxic condition.
    Yan B; Li T; Shen L; Zhou Z; Liu X; Wang X; Sun X
    Biochem Biophys Res Commun; 2019 Jul; 515(2):275-281. PubMed ID: 31146919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
    Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
    Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
    Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H
    Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.